CT New Haven의 비소세포폐암 임상 시험
비소세포폐암 관련 연구 41개가 New Haven 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Yale New Haven Hospital /ID# 271584, New Haven
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
피험자 모집 중3상
- Yale University, New Haven
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven · 3마일 거리
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- 외 2개
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
피험자 모집 중3상
- Yale University School of Medicine ( Site 0201), New Haven
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #62, New Haven
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
피험자 모집 중3상
- Smilow Cancer Center at Yale-New Haven ( Site 3253), New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
피험자 모집 중2상
- Yale Cancer Center, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
피험자 모집 중1상
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
피험자 모집 중1상
- Yale Cancer Center, New Haven
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
피험자 모집 중3상
- Yale University, Smillow Cancer Center, New Haven
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Yale University, New Haven
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Yale New Haven Hospital Yale Cancer Center, New Haven
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
피험자 모집 중2상
- Research Site, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
피험자 모집 중1상
- Yale University, Yale Cancer Center, New Haven
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중3상
- Research Site, West Haven · 3마일 거리
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
피험자 모집 중1상
- Yale Cancer Center, New Haven
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- Yale University School of Medicine - Yale Cancer Center, New Haven
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중2상
- Yale Cancer Center, New Haven
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
피험자 모집 중1상
- Yale Cancer Center, New Haven
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- Yale University School of Medicine, New Haven
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
피험자 모집 중1상
- Yale Cancer Center, New Haven
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
피험자 모집 중1상
- Yale Cancer Center, New Haven
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
피험자 모집 중1/2상
- Yale University, New Haven
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
피험자 모집 중3상
- Research Site, New Haven
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
피험자 모집 중1/2상
- Yale University, New Haven
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
피험자 모집 중1/2상
- Yale University - Cancer Center, New Haven
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
피험자 모집 중1/2상
- Yale New Haven Hospital, Yale Cancer Center, New Haven
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
피험자 모집 중1/2상
- Smilow Cancer Hospital, New Haven
- Smilow Cancer Hospital - Hamden Care Center, Hamden · 6마일 거리
- Smilow Cancer Hospital Care Center - Guilford, Guilford · 13마일 거리
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
피험자 모집 중1상
- Yale University School of Medicine /ID# 225707, New Haven
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
피험자 모집 중2상
- Yale University, New Haven
- Smilow Cancer Hospital-Orange Care Center, Orange · 5마일 거리
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- 외 2개
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
피험자 모집 중1상
- Yale University, New Haven
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- Smilow Cancer Hospital-Derby Care Center, Derby · 8마일 거리
- 외 1개
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2/3상
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- Smilow Cancer Hospital-Derby Care Center, Derby · 8마일 거리
- 외 1개
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
피험자 모집 중2상
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7마일 거리
- Smilow Cancer Hospital-Derby Care Center, Derby · 8마일 거리
- 외 1개
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
피험자 모집 중2상
- Smilow Cancer Hospital at Yale - New Haven, New Haven
- Yale-New Haven Hospital- Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- 외 1개
Repositioning Immunotherapy in VetArans With Lung Cancer
피험자 모집 중2상
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven · 3마일 거리
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
피험자 모집 중1/2상
- Yale University, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
피험자 모집 중1/2상
- Yale Cancer Center, New Haven
다른 도시의 비소세포폐암 시험
- Houston, TX연구 145개
- New York City, NY연구 121개
- Arlington, VA연구 104개
- Nashville, TN연구 97개
- Boston, MA연구 90개
- Los Angeles, CA연구 87개
- St. Louis, MO연구 73개
- Chicago, IL연구 61개
- Baltimore, MD연구 60개
- San Antonio, TX연구 59개
- Columbus, OH연구 57개
- Washington, DC연구 55개
New Haven의 다른 연구
- 유방암연구 38개
- 암 (전체)연구 33개
- 전이성 암연구 23개
- 폐암연구 22개
- 두경부 편평세포암연구 22개
- 난소암연구 21개
- 대장직장암연구 20개
- 전립선암연구 20개
- 급성 골수성 백혈병연구 17개
- 알코올 사용 장애(AUD)연구 17개
- 오피오이드 과다 복용연구 17개
- 췌장암연구 16개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.